Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Rodrigues
C
C
Kumar
N J
NJ
Lalwani
J
J
Mehta
A
A
D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D007194:India; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests / Q000379:methods; D011247:Pregnancy; D012485:Salmonella typhi / Q000187:drug effects* / Q000302:isolation & purification; D014435:Typhoid Fever / Q000188:drug therapy / Q000382:microbiology*
D002939:Ciprofloxacin